Pharmacodynamic Evaluation of Intramuscular Nalmefene Autoinjector 1.5 mg Compared to Intranasal Narcan 4 mg

Clinical trial NCT06719986 · COMPLETED

Trial details

NCT number: NCT06719986
Sponsor: Purdue Pharma LP
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Opioid Overdose

Start date: 2022-10-03
Primary completion: 2022-12-23
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.